Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinical and immune features of CD14 in colorectal cancer identified via large-scale analysis.

International immunopharmacology - 1 Nov 2020

Chen Datian, Wang Huiyu

Abstract excerpt

BACKGROUND: Cancer immunotherapies have achieved great progress in colorectal cancer (CRC). However, only a small subset of CRC patients with microsatellite instability (MSI) can obtain benefits from immune checkpoint inhibitors (ICIs). Nearly 85% of all CRC patients have microsatellite-stable (MSS) disease, which does not respond to ICIs. Increasing evidence has revealed that CD14 promotes tumor growth and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to DNA Copy Number Variations
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipopolysaccharide Receptors

Share to Mutation

Share to Prognosis

Share to RNA-Seq

Share to Transcriptome

Source

Identifiers

PMID: 33182067
DOI: 10.1016/j.intimp.2020.106966

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinical and immune features of CD14 in colorectal cancer identified via large-scale analysis.PMID 33182067Read ↗

Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal CancerSemantic proximity Read ↗

TNMD in pan-cancer analysis: Exploring its impact on immune modulation and uncovering functional insights in colorectal cancerSemantic proximity Read ↗

Aberrant expression of CD14 in breast tumor cells is associated with poor outcomeSemantic proximity Read ↗

Data Mining Suggests That CXCL14 Gene Silencing in Colon Cancer Is Due to Promoter MethylationSemantic proximity Read ↗

CXCL14 suppresses the progression of colon cancer by regulating tumor epithelial-mesenchymal transition and tumor microenvironmentSemantic proximity Read ↗

Data Mining Suggests that CXCL14 Gene Silencing in Colon Cancer is Due to Promoter MethylationSemantic proximity Read ↗

Subtyping of microsatellite instability-high colorectal cancerSemantic proximity Read ↗

B7H4 Expression Is More Frequent in MSS Status Colorectal Cancer and Is Negatively Associated with Tumour Infiltrating LymphocytesSemantic proximity Read ↗

Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatmentSemantic proximity Read ↗

Prognostic Biomarker SPOCD1 and Its Correlation with Immune Infiltrates in Colorectal CancerSemantic proximity Read ↗

Apolipoprotein C1 as a Novel Biomarker for Evaluating Immunotherapy Drug Responses and Clinical Prognosis for Microsatellite Unstable Colorectal CancerSemantic proximity Read ↗

Epigenetic-related gene mutations serve as potential biomarkers for immune checkpoint inhibitors in microsatellite-stable colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.